Computer visualization techniques (CVTs) foster evidence-based target delineation.

Abstract:

:Computer visualization techniques (CVTs) are an emerging technology that can organize all cancer specialists. This article describes CVTs' ability to maximize the currently untapped advantages of intensity modulated radiotherapy (IMRT). The visual speed and dynamic strategies inherent in CVTs improves IMRT by distilling vast amounts of anatomic, multimodal imaging, textual/meaning, and surgical/outcome data into a large, rigorous, standardized evidence base of storable target delineation plans. This ability to standardize strategies will allow the collection of meaningful evidence based outcome data.

journal_name

Cancer Invest

journal_title

Cancer investigation

authors

Butler EB,Shukla V,Paulino AC,Lu HH,Butler R,Smiedala M,Kurk J,Grant WH 3rd,McGary JE,Teh BS

doi

10.1080/07357900600970490

subject

Has Abstract

pub_date

2007-02-01 00:00:00

pages

1-5

issue

1

eissn

0735-7907

issn

1532-4192

pii

773165244

journal_volume

25

pub_type

杂志文章
  • Corticosteroids in cancer: neuropsychiatric complications.

    abstract::The addition of corticosteroids in the early 1950s to the treatment armamentarium provided cure of some diseases and control of many. They have become an integral part of many cancer treatment regimens. Early reports of severe affective disorders appear less frequent today in patients receiving steroids, though contro...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357908909041378

    authors: Stiefel FC,Breitbart WS,Holland JC

    更新日期:1989-01-01 00:00:00

  • Phase II trial of 96-hour paclitaxel in previously treated patients with advanced esophageal cancer.

    abstract:BACKGROUND:A 96-hour infusion schedule of paclitaxel demonstrates tolerability and antitumor activity in lung cancer and breast cancer refractory to short-duration infusion paclitaxel. Given the activity of paclitaxel in esophageal cancer, a phase II trial of 96-hour infusion paclitaxel in esophageal cancer was underta...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.1081/cnv-120022360

    authors: Anderson SE,O'Reilly EM,Kelsen DP,Ilson DH

    更新日期:2003-01-01 00:00:00

  • The effect of castration on the synthesis and secretion of proteins in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.

    abstract:UNLABELLED:The effect of castration on the incorporation of [35S]methionine into secreted proteins in 7,12-dimethylbenz(a)anthracene (DMBA)-induced rat mammary tumors, was investigated. Biopsy specimens were obtained from 19 tumors, 0, 24, 48, 72, and 96 h after castration. In 14 tumors, castration induced an increase ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909209032762

    authors: Geier A,Hemi R,Beery R,Lunenfeld B

    更新日期:1992-01-01 00:00:00

  • Lung Cancer in Never-Smoking Women: A Sub-Analysis of the Spanish Female-Specific Database WORLD07.

    abstract::The WORLD07 study characterizes lung cancer in Spanish women. This analysis investigated lung cancer features in never-smoking women. Of 2072 women recruited, 2035 were analyzed. Patient characteristics and demographics were similar for current/former smokers and never smokers. Among never smokers, 38.3% were exposed ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,多中心研究

    doi:10.1080/07357907.2017.1295461

    authors: Viñolas N,Garrido P,Isla D,Provencio M,Majem M,Artal A,Carcereny E,Garcia Campelo R,Lianes P,De La Peñas R,Felip E

    更新日期:2017-05-28 00:00:00

  • Mitochondrial DNA alterations in cancer.

    abstract::A number of studies have demonstrated the presence of mitochondrial DNA (mtDNA) mutations in cancer cells. In this article, we review mitochondrial genomic aberrations reported in solid tumors of the breast, colon, stomach, liver, kidney, bladder, head/neck, and lung. The tantalizing association of tumors with mtDNA m...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-120002155

    authors: Copeland WC,Wachsman JT,Johnson FM,Penta JS

    更新日期:2002-01-01 00:00:00

  • Genetic testing for inherited breast cancer risk in African Americans.

    abstract::As genetic testing for BRCA1 and BRCA2 (BRCA1/2) mutations is increasingly integrated into the clinical management of high-risk women, it will be important to understand barriers and motivations for genetic counseling among women from underserved minority groups to ensure equitable access to these services. Therefore,...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-58819

    authors: Halbert CH,Kessler LJ,Mitchell E

    更新日期:2005-01-01 00:00:00

  • Prognostic significance of extracellular matrix degrading enzymes-cathepsin L and matrix metalloproteases-2 [MMP-2] in human pancreatic cancer.

    abstract::In the present study, we assessed the expression of extracellular matrix (ECM) degrading proteases-cathepsin L and matrix metalloprotease-2 (MMP-2) in pancreatic cancer tissue and correlated their levels with clinicopathological parameters and survival. Both the proteases were expressed in the majority of the tumor ti...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2013.820318

    authors: Singh N,Das P,Datta Gupta S,Sahni P,Pandey RM,Gupta S,Chauhan SS,Saraya A

    更新日期:2013-08-01 00:00:00

  • Comparative physical and pharmacologic characteristics of iodine-131 and yttrium-90: implications for radioimmunotherapy for patients with non-Hodgkin's lymphoma.

    abstract::Radioimmunotherapy (RIT) is a promising new treatment option for patients with relapsed/refractory non-Hodgkin's lymphoma. Clinical trials have demonstrated that both iodine-131 (131I) and yttrium-90 (90Y) are suitable radionuclides for RIT. Iodine-131 and 90Y differ markedly in their physical properties including hal...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-120016421

    authors: Leonard JP,Siegel JA,Goldsmith SJ

    更新日期:2003-04-01 00:00:00

  • Targeted therapy for renal cell carcinoma: a new therapeutic paradigm.

    abstract::Renal cell carcinoma is the most common tumor of the kidney. It has an unpredictable behavior and poor response to systemic therapy. Developing newer therapy for this disease is a priority considering the high recurrence rate and the small subset of patients who benefit from the use of cytokines such as interferon-alp...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900600896315

    authors: Shaheen PE,Bukowski RM

    更新日期:2006-10-01 00:00:00

  • A thousand points of light or just dim bulbs? Radiolabeled antibodies and colorectal cancer imaging.

    abstract::Radioimmunoscintigraphy (RIS) is coming into its own as an imaging modality in clinical oncology. Early experience with indium-111-labeled intact murine monoclonal antibodies (MoAbs) in colorectal cancer suggested that RIS images hepatic metastases poorly. Moreover, an antimurine immune response was frequently provoke...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357909909032874

    authors: Moffat FL Jr,Gulec SA,Serafini AN,Sfakianakis GN,Pop R,Robinson DS,Franceschi D,Boggs J,Livingstone AS

    更新日期:1999-01-01 00:00:00

  • Inhibition of vascular endothelial growth factor by octreotide in colorectal cancer patients.

    abstract::Vascular endothelial growth factor (VEGF) seems to be essential for angiogenesis and for the growth of colorectal cancer; thus its inhibition can arrest tumor growth and decrease metastatic potential. Octreotide has been shown to inhibit growth of colorectal tumors in vitro and in vivo. Part of the antiproliferative a...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-100000069

    authors: Cascinu S,Del Ferro E,Ligi M,Staccioli MP,Giordani P,Catalano V,Agostinelli R,Muretto P,Catalano G

    更新日期:2001-01-01 00:00:00

  • Glyoxalase I Glu111Ala polymorphism in patients with breast cancer.

    abstract::Effect of advanced glycation end products (AGEs) in the pathogenesis of cancer could be diminished by interaction with soluble RAGE or by reducing AGE-precursors via glyoxalase I. Glu111Ala polymorphism of glyoxalase I gene, AGEs, and sRAGE serum levels were studied in 113 breast cancer patients and in 58 controls. Hi...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802350822

    authors: Germanová A,Germanová A,Tesarová P,Jáchymová M,Zvára K,Zima T,Kalousová M

    更新日期:2009-07-01 00:00:00

  • Correlation between MIB1-determined tumor growth fraction and incidence of tumor recurrence in early ovarian carcinomas.

    abstract:PURPOSE:The decision concerning adjuvant therapy remains difficult in patients with very early stage ovarian carcinomas [Fédération Internationale de Gynécologie et d' Obstétrique (FIGO) Ia/b]. Therefore, we compared the MIB1-determined tumor growth fraction in archival tumor tissue with tumor recurrence and outcome of...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-120030206

    authors: Münstedt K,von Georgi R,Franke FE

    更新日期:2004-01-01 00:00:00

  • Single-dose granulocyte colony-stimulating factor concomitant with multifractionated dose chemotherapy: a strategy for maintaining dose intensity.

    abstract::Multifractionated dosing (MFD) schedules for chemotherapy administration such as weekly or twice weekly administration are intended to maximize dose intensity while minimizing toxicity, but the cumulative drug effect may result in neutropenia necessitating interruption of dose fractions and thereby compromising dose i...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909909032865

    authors: Lokich J

    更新日期:1999-01-01 00:00:00

  • Synergistic Effects of PI3K and c-Myc Co-targeting in Acute Leukemia: Shedding New Light on Resistance to Selective PI3K-δ Inhibitor CAL-101.

    abstract::Enthusiasms into the application of PI3K-δ inhibitor CAL-101 has been muted due to the over-activation of compensatory molecules. Our results delineated that c-Myc suppression using 10058-F4 enhanced CAL-101 cytotoxicity in less sensitive cells through different mechanisms based on p53 status; while CAL-101-plus-10058...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1651328

    authors: Riyahi N,Safaroghli-Azar A,Sheikh-Zeineddini N,Sayyadi M,Bashash D

    更新日期:2019-01-01 00:00:00

  • Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment.

    abstract::The interaction of 5-fluorouracil and cyclophosphamide in the treatment of L1210 and P388 leukemias was studied using response surface methodology. Single dose treatment of each drug was administered simultaneously or with a 24-hr interval between 5-fluorouracil and cyclophosphamide to the advanced tumors or at variou...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908709020311

    authors: Wampler GL,Carter WH Jr,Campbell ED

    更新日期:1987-01-01 00:00:00

  • Heterogeneity in TPA-induced differentiation of B-chronic lymphocytic leukemia cells: development of hairy cell or plasmacytoid features are time and dose dependent.

    abstract::Cells from 11 chronic lymphocytic leukemic (CLL) patients were induced to differentiate with various doses of tetradecanoyl phorbol-13-acetate (TPA) and the degree of induction was followed up to six days by measuring the expression of two surface membrane markers (SmIg and GP-70), Ig secretion, tartrate-resistant aci...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:

    authors: Gazitt Y,Gurfel D,Leizerowitz R,Feinstein H,Polliack A

    更新日期:1987-01-01 00:00:00

  • Comparison of the expression of P-glycoprotein, Ki-67, and P-53 to technetium-99m tetrofosmin mammoscintigraphic findings.

    abstract::Adjuvant and neoadjuvant chemotherapy is being used increasingly in the treatment of breast cancer patients. However, drug resistance plays an important role in the failure of chemotherapy in breast cancer. The aim of this study was to compare technetium-99m tetrofosmin (Tc-TETRO) mammoscintigraphic findings with the ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-120001147

    authors: Liu TJ,Tsai SC,Ho YJ,Sun SS,Kao CH

    更新日期:2002-01-01 00:00:00

  • A Phase II NCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancer.

    abstract:PURPOSE:This Phase II study was undertaken to define the efficacy and toxicity of the combination of docetaxel and irinotecan for the second-line treatment of non-small cell lung cancer (NSCLC). PATIENTS AND METHODS:Forty-six patients with measurable NSCLC who had relapsed after an initial response to chemotherapy or ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,多中心研究

    doi:10.1080/07357900600705318

    authors: Molina JR,Nikcevich D,Hillman S,Geyer S,Drevyanko T,Jett J,Verdirame J,Tazelaar H,Rowland K,Wos E,Kutteh L,Nair S,Fitch T,Flynn P,Stella P,Adjei AA

    更新日期:2006-06-01 00:00:00

  • Progesterone challenge test in postmenopausal women with pathological endometrium.

    abstract::Cytosolic and nuclear progesterone receptor levels (RPC, RPN) were measured in normal and in pathological human endometria after single-dose progesterone injection 1-3 h before tissue collection (test subjects) and the results compared to those obtained in controls (no progesterone treatment). In test cases of late pr...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908809082116

    authors: Gorodeski IG,Geier A,Lunenfeld B,Bahary CM

    更新日期:1988-01-01 00:00:00

  • Evaluation of Cytotoxic Potentials of Novel Cyclooxygenase-2 Inhibitor against ALL Lymphocytes and Normal Lymphocytes and Its Anticancer Effect through Mitochondrial Pathway.

    abstract::In the present study, we searched selective cytotoxicity and mitochondria mediated apoptosis of novel COX-2 inhibitor 2-(4-(Methylsulfonyl)phenyl)imidazo[1,2-a] pyridine-8-carboxylic acid on B-lymphocytes and their mitochondria isolated from normal subjects and acute lymphoblastic leukemia (ALL) patients' blood. Our r...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2020.1808898

    authors: Salimi A,Aghvami M,Azami Movahed M,Zarei MH,Eshghi P,Zarghi A,Pourahmad J

    更新日期:2020-09-01 00:00:00

  • Immune senescence: mechanisms and clinical implications.

    abstract::There are many changes in the immune response with age, most of which can be related to the involution of the thymus gland and alteration of the distribution and function of T lymphocytes. These changes indirectly influence B-cell function, which not only amplifies the immune deficits, but leads to the increased produ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357909209024815

    authors: Ben-Yehuda A,Weksler ME

    更新日期:1992-01-01 00:00:00

  • Necrotic lung and bronchopleural fistula as complications of therapy in lung cancer.

    abstract::Seven patients developed a lung abscess and bronchopleural fistula after undergoing aggressive treatment of their lung cancer with radiotherapy +/- chemotherapy. These complications were preceded by a prodrome of recurrent bronchitis with increasing refractoriness to antibiotics, weight loss, fever, and generalized de...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908809077041

    authors: Frytak S,Lee RE,Pairolero PC,Arnold PG,Shaw JN

    更新日期:1988-01-01 00:00:00

  • A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung cancer.

    abstract::Standard chemotherapeutic regimens, such as cisplatin and etoposide, may improve quality of life and prolong survival in patients with incurable non-small cell lung cancer (NSCLC). This trial was designed to evaluate the activity and toxicity of a regimen combining three of the most active agents against advanced-stag...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.3109/07357900009023055

    authors: Ali MA,Kraut MJ,Valdivieso M,Wozniak AJ,Cummings G,Kalemkerian GP

    更新日期:2000-01-01 00:00:00

  • Tamoxifen Never Ceases to Amaze: New Findings on Non-Estrogen Receptor Molecular Targets and Mediated Effects.

    abstract::Tamoxifen is a first targeted drug that continues to be the gold standard in treatment of estrogen receptor positive breast cancer for almost 50 years. The current review is an update of the paper published in 2012. We provide the new data on the tamoxifen targets that are the key points of signaling cascades activati...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357907.2018.1453933

    authors: Bogush TA,Polezhaev BB,Mamichev IA,Bogush EA,Polotsky BE,Tjulandin SA,Ryabov AB

    更新日期:2018-04-21 00:00:00

  • Temozolomide treatment of an adult with a relapsing medulloblastoma.

    abstract::Temozolomide is an oral cytotoxic agent that has demonstrated its interest in high grade glioma tumors. This drug can be used either concomitantly with radiotherapy or as chemotherapy. The prognosis of relapsing medulloblastoma is poor and treatment is often difficult, especially after radiotherapy. Here, we report th...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701518164

    authors: Durando X,Thivat E,Gilliot O,Irthum B,Verrelle P,Vincent C,Bay JO

    更新日期:2007-09-01 00:00:00

  • Trends in Survival Based on Treatment Modality in Non-Small Cell Lung Cancer Patients: A Population-Based Study.

    abstract::Objectives: We examined the trends in survival based on treatment modality among non-small cell lung cancer (NSCLC) patients in the province of Ontario, Canada, from 2007 to 2015. Methods: We investigated the trends in survival based on treatment modality. Results: Among 56,417 identified patients, the mean age at dia...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1653465

    authors: Akhtar-Danesh N,Akhtar-Danseh GG,Seow HY,Shakeel S,Finley C

    更新日期:2019-01-01 00:00:00

  • Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: report of two cases and review of literature.

    abstract::Placement of carmustine-impregnated wafers has become a common practice after surgical resection of malignant gliomas. Bevacizumab is used as a second-line agent for the treatment of malignant gliomas and is sometimes used in patients who have had recent wafer implantation. We describe two cases of fatal cerebrospinal...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357907.2010.483499

    authors: Nagaiah G,Almubarak M,Khan M,Altaha R

    更新日期:2010-12-01 00:00:00

  • Ammonium sulfate fractionation and assay of hormone receptors.

    abstract::Ammonium sulfate (AS) precipitation by consecutive steps at 10% to 50% saturation has been utilized for fractionation of cytoplasmic estrogen receptor (ER) and progesterone receptor (PgR). The highest percentage of both receptor activities are confined mainly in two fractions at AS saturation from 20% to 30% and 30% t...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908909039842

    authors: Chen YM,Vaughn CB

    更新日期:1989-01-01 00:00:00

  • Methylated tumor-specific DNA as a plasma biomarker in patients with glioma.

    abstract:OBJECTIVE:Patients with systemic malignancies have substantial quantities of tumor-specific DNA in their plasma which may serve as a potential biomarker for tumor burden. This approach has not been studied in gliomas. METHODS:Methylation specific polymerase chain reaction (MSP) was used to determine the methylation st...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900500449546

    authors: Weaver KD,Grossman SA,Herman JG

    更新日期:2006-02-01 00:00:00